Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized switch trial of Dovato versus Biktarvy in adults with HIV-1
2020-000685-42Phase 4Active
- Sponsor
- Ghent University Hospital
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Human immunodeficiency virus infection type 1 comparing Dovato arm with Biktarvy arm (2 arms). Started Mar 2020; status: active.
02
Drugs
dolutegravir + lamivudinebictegravir + emtricitabine + tenofovir alafenamide
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2020-000685-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000685-42.